Clinical trial
Study of ONO-1078 in Patients With Chronic Sinusitis
NCT00410735 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00410735 |
|---|---|
| Title | Study of ONO-1078 in Patients With Chronic Sinusitis |
| Official title | Study of ONO-1078 in Patients With Chronic Sinusitis, a Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Sinusitis |
| Intervention type | Drug |
| Interventions | Placebo, Pranlukast hydrate |
| Enrollment | 495 |
| Start date | Dec 1, 2006 |
| Primary completion | Jun 1, 2008 |
| First posted | Dec 13, 2006 |
| Last update posted | Jun 13, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: